Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia.

BMC Microbiology
Angela R BoydCarlos J Orihuela

Abstract

Recent studies suggest that the reported protective effects of statins (HMG-CoA reductase inhibitors) against community-acquired pneumonia (CAP) and sepsis in humans may be due to confounders and a healthy user-effect. To directly test whether statins are protective against Streptococcus pneumoniae, the leading cause of CAP, we examined the impact of prolonged oral simvastatin therapy at physiologically relevant doses in a mouse model of pneumococcal pneumonia. BALB/c mice were placed on rodent chow containing 0 mg/kg (control), 12 mg/kg (low simvastatin diet [LSD]; corresponds to 1.0 mg/kg/day), or 120 mg/kg (high simvastatin diet [HSD]; corresponds to 10 mg/kg/day) simvastatin for four weeks, infected intratracheally with S. pneumoniae serotype 4 strain TIGR4, and sacrificed at 24, 36, or 42 h post-infection for assessment of lung histology, cytokine production, vascular leakage and edema, bacterial burden and bloodstream dissemination. Some mice received ampicillin at 12-h intervals beginning at 48 h post-infection and were monitored for survival. Immunoblots of homogenized lung samples was used to assess ICAM-1 production. Mice receiving HSD had reduced lung consolidation characterized by less macrophage and neutrophil infi...Continue Reading

References

Aug 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·M KimuraD N Granger
Mar 1, 2000·Biochemical and Biophysical Research Communications·S TakeuchiM Yokoyama
Apr 12, 2003·Critical Care Medicine·Edward Abraham
Aug 4, 2004·Circulation·Yaniv AlmogAbraham Danon
Oct 13, 2004·The Journal of Infectious Diseases·Carlos J OrihuelaElaine I Tuomanen
Dec 14, 2004·American Journal of Respiratory and Critical Care Medicine·Michael B FesslerG Scott Worthen
Apr 30, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Heiko MetheMichael Weis
Feb 21, 2006·Current Biology : CB·Katharina BeiterBirgitta Henriques-Normark
Aug 23, 2006·Clinical and Experimental Pharmacology & Physiology·Hong-Wei YaoJian-Ping Zhu
Jan 16, 2007·Cellular Microbiology·Florian WarthaBirgitta Henriques-Normark
Feb 14, 2007·Infection and Immunity·Matthew MarksLiise-anne Pirofski
Dec 19, 2007·The Journal of Antimicrobial Chemotherapy·S Jerwood, J Cohen
Mar 28, 2009·American Journal of Respiratory and Critical Care Medicine·Murali ShyamsundarDaniel F McAuley
Jul 10, 2009·The Journal of Infectious Diseases·Ernesto HinojosaCarlos J Orihuela
Oct 14, 2009·Archives of Internal Medicine·Imad M TleyjehTalal Ibrahim
Dec 22, 2009·La Presse médicale·Luc de Saint MartinElisabeth Pasquier
Jan 23, 2010·The Journal of Clinical Investigation·Jason W RoschElaine I Tuomanen
Aug 3, 2010·Critical Care : the Official Journal of the Critical Care Forum·Holger C MüllerMartin Witzenrath
Oct 27, 2010·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Richard A MillerRandy Strong
Nov 16, 2010·Cell Host & Microbe·Ohn A ChowVictor Nizet
Apr 26, 2011·Critical Care Medicine·Sachin YendeDerek C Angus
Jul 19, 2011·The Journal of Infection·Vicente F Corrales-Medina, Daniel M Musher
Sep 14, 2011·PloS One·Peter BergmanLinda Björkhem-Bergman

❮ Previous
Next ❯

Citations

Jul 31, 2012·Current Infectious Disease Reports·Joel D Mermis, Steven Q Simpson
Jul 9, 2013·Antiviral Research·David S Fedson
May 15, 2013·The Journal of Infection·D P R TroemanJ J Oosterheert
May 10, 2013·Current Opinion in Pediatrics·Erica M Carlisle, Michael J Morowitz
Oct 3, 2012·Critical Care : the Official Journal of the Critical Care Forum·Peter S Kruger, Robert M Thomas
Nov 28, 2013·Current Atherosclerosis Reports·Peter S Kruger, Bala Venkatesh
Nov 7, 2015·National Science Review·Sarita R ShahAntonios G Mikos
Apr 11, 2014·The Lancet. Respiratory Medicine·Pallavi MandalAdam T Hill
Apr 21, 2016·Drug Discovery Today·Nathalie M VandeveldeFrançoise Van Bambeke
Jun 22, 2016·Antimicrobial Agents and Chemotherapy·Emma HennessyFergal O'Gara
Nov 26, 2014·Infection and Immunity·Norberto González-JuarbeMolly A Bergman
Sep 23, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kate H Regan, Adam T Hill
Jun 24, 2017·Current Infectious Disease Reports·Mohammed A BataisAref A Bin Abdulhak
Apr 11, 2013·Current Opinion in Infectious Diseases·Joshua Vernatter, Liise-anne Pirofski
Nov 30, 2018·Nature Reviews. Immunology·Suraj P PariharFrank Brombacher
Feb 2, 2017·Frontiers in Cellular and Infection Microbiology·Wei-Chih LiaoChih-Ho Lai
Oct 29, 2020·Mediators of Inflammation·Flora Magno de Jesus OliveiraHugo Caire de Castro Faria Neto
May 8, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Luciana P TavaresFrancesca Levi-Schaffer

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
bronchoalveolar
bronchoalveolar lavage

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

American Journal of Physiology. Lung Cellular and Molecular Physiology
Jeffrey R JacobsonJoe G N Garcia
American Journal of Respiratory and Critical Care Medicine
Murali ShyamsundarDaniel F McAuley
Proceedings of the National Academy of Sciences of the United States of America
Kevin B WalshMichael B A Oldstone
© 2021 Meta ULC. All rights reserved